Infant Immunity Comparison of Breastfed and Bottlefed Infants
NCT ID: NCT02568579
Last Updated: 2018-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
85 participants
OBSERVATIONAL
2015-01-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight Infants
NCT00005888
Impact of Feeding on Pro-Inflammatory Cytokine Response in Neonates Receiving a RBC Transfusion
NCT01949896
Effects of Complementary Feeding on Infant Growth and Gut Health
NCT05012930
Effect of Oligosaccharides and Optimizing Multiple Nutrients to Infant Formula on Growth and Development of Infants
NCT06569797
Human Milk Fortifier and Cytokine Profile
NCT00601081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breastfed
collection of blood/stool/breast milk samples and information about feeding changes and introduction of solid foods. - Cord Blood sample, stool samples monthly and blood sample at 6 month and 12 months of age
blood sample/ stool sample
blood sample to be done when possible with standard of care lab draw. Stool sample to be collected monthly at home.
Bottlefed
collection of blood/stool samples and information about feeding changes and introduction of solid foods. Coord blood sample, stool samples monthly and blood sample at 6 month and 12 month of age.
blood sample/ stool sample
blood sample to be done when possible with standard of care lab draw. Stool sample to be collected monthly at home.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sample/ stool sample
blood sample to be done when possible with standard of care lab draw. Stool sample to be collected monthly at home.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years or older at the time of consent
* Willing and able to sign consent and follow study schedule
* Planned vaginal delivery
* Willing to primarily breastfed or formula feed for the first four months
Exclusion Criteria
* Unwillingness to exclusively breast feed or formula feed their infant for at least the first 4 months
* Unwillingness to receive standard immunizations on the schedule recommended by the American Academy of Pediatrics
* Chronic maternal condition that may influence infant immunity including but not limited to: maternal HIV, immunodeficiency, use of immunosuppressive medications, malignancy or autoimmunity
* Known fetal medical conditions such as congenital malformations
* Use of immune modulating/immune suppressive medication and prophylactic antibiotics during pregnancy
* Any condition that may prevent a mother who plans to breast feed from breast feeding
* Any condition that in the opinion of the investigator would interfere with the conduct of the study
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of South Florida
OTHER
Children's Hospital Los Angeles
OTHER
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Sleasman, MD
Role: STUDY_DIRECTOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Los Angeles
Los Angeles, California, United States
UNC Chapel Hill
Chapel Hill, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00050219
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.